Literature DB >> 24156968

Does the presence of accessory renal arteries affect the efficacy of renal denervation?

Dani Id1, Benjamin Kaltenbach, Stefan C Bertog, Marius Hornung, Ilona Hofmann, Laura Vaskelyte, Horst Sievert.   

Abstract

OBJECTIVES: This study sought to assess the efficacy of catheter-based renal sympathetic denervation in patients with accessory renal arteries and to compare the blood pressure (BP)-lowering effect with that observed in patients with bilateral single renal arteries after renal denervation.
BACKGROUND: Catheter-based renal sympathetic denervation causes significant BP reductions in patients with resistant hypertension.
METHODS: Seventy-four patients were included in this study. Patients were assigned to 2 main groups: a bilateral single renal arteries group I (n = 54) and an accessory renal arteries group II (n = 20). Group II consisted of 9 patients whose accessory renal arteries were all denervated (group IIa), and 11 patients whose accessory renal arteries were not, or only incompletely, denervated (group IIb). The primary endpoint was the change in office systolic BP after 6 months.
RESULTS: The procedure was successful in all patients. Group I: mean BP at baseline was 166.2/89.4 ± 20.5/14.6 mm Hg and decreased by -16.6 (p < 0.001)/-6.7 (p = 0.016) ± 16.4/11 mm Hg at 6-month follow-up. Group II: mean BP at baseline was 164.2/89.1 ± 19.9/15.4 mm Hg and decreased by -6.2 (p = 0.19)/-0.2 (p = 0.5) ± 19.7/11.3 mm Hg at 6-month follow-up. Patients in group IIa had an office BP reduction of -8.8 (p = 0.2)/1.1 ± 17.9/10.8 mm Hg and patients in group IIb of -4.1 (p = 0.55)/-1.3 ± 20.8/11.6 mm Hg. Similarly, significant improvements in 24-h mean systolic BP were seen in group I (-8.3 ± 17.4 mm Hg, p < 0.01), whereas none were seen in group II (-3.7 ± 8.3 mm Hg, p = 0.38).
CONCLUSIONS: BP reduction achieved after renal denervation in patients with accessory renal arteries is less pronounced than in patients with bilateral single renal arteries.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BP; accessory; arterial hypertension; blood pressure; eGFR; estimated glomerular filtration rate; radiofrequency ablation; renal artery; renal denervation

Mesh:

Year:  2013        PMID: 24156968     DOI: 10.1016/j.jcin.2013.06.007

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  15 in total

Review 1.  The rise, fall, and possible resurrection of renal denervation.

Authors:  Rajiv Gulati; Claire E Raphael; Manuela Negoita; Stuart J Pocock; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

2.  Renal sympathetic denervation for resistant hypertension: a transiently sustained placebo effect?

Authors:  T E Purvis; K E Shipman; R Watkin; J Freedman; P Crowe; I Dasgupta
Journal:  J Hum Hypertens       Date:  2014-11-06       Impact factor: 3.012

3.  Catheter-Based Radiofrequency Renal Denervation: Location Effects on Renal Norepinephrine.

Authors:  Jeffrey R Henegar; Yongxing Zhang; Cary Hata; Irvin Narciso; Michael E Hall; John E Hall
Journal:  Am J Hypertens       Date:  2015-01-08       Impact factor: 2.689

4.  Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.

Authors:  Enrique Ponce de Leon-Martinez; Javier A Garza; Jose R Azpiri-Lopez; Krista N Dillon; Leonel Olivas Salazar; Francisco Canepa-Campos; Serge D Rousselle; Armando Tellez
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-27

Review 5.  Hypothesis: Accessory renal arteries may be an overlooked cause of renin-dependent hypertension.

Authors:  Mario Funes Hernandez; Vivek Bhalla; Robert T Isom
Journal:  J Hum Hypertens       Date:  2021-11-16       Impact factor: 3.012

Review 6.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

Review 7.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

Review 8.  A perspective on sympathetic renal denervation in chronic congestive heart failure.

Authors:  Raef Madanieh; Mohammed El-Hunjul; Hassan Alkhawam; Constantine E Kosmas; Abed Madanieh; Timothy J Vittorio
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

Review 9.  Renal denervation for the management of resistant hypertension.

Authors:  Hitesh C Patel; Carl Hayward; Vassilis Vassiliou; Ketna Patel; James P Howard; Carlo Di Mario
Journal:  Integr Blood Press Control       Date:  2015-12-03

10.  Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteries.

Authors:  Farrell O Mendelsohn
Journal:  Clin Res Cardiol       Date:  2014-03-26       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.